Nefazodone

You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.

Jump to: navigation, search

Synonyms / Brand Names: Nefazodona, Nefazodone Hcl, Nefazodone hydrochloride, Nefazodonum, Dutonin, Serzone

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Phone:617-525-6884

Dosing and Administration

The recommended starting dose for Nefazodone hydrochloride tablets is 200 mg/day, administered in two divided doses (BID). In the controlled clinical trials establishing the antidepressant efficacy of Nefazodone, the effective dose range was generally 300 to 600 mg/day. Consequently, most patients, depending on tolerability and the need for further clinical effect, should have their dose increased. Dose increases should occur in increments of 100 mg/day to 200 mg/day, again on a BID schedule, at intervals of no less than 1 week. As with all antidepressants, several weeks on treatment may be required to obtain a full antidepressant response.



FDA Package Insert Resources
Indications, Contraindications, Side Effects, Drug Interactions, etc.

Calculate Creatine Clearance
On line calculator of your patients Cr Cl by a variety of formulas.

Convert pounds to Kilograms
On line calculator of your patients weight in pounds to Kg for dosing estimates.

Publication Resources
Recent articles, WikiDoc State of the Art Review, Textbook Information

Trial Resources
Ongoing Trials, Trial Results

Guidelines & Evidence Based Medicine Resources
US National Guidelines, Cochrane Collaboration, etc.

Media Resources
Slides, Video, Images, MP3, Podcasts, etc.

Patient Resources
Discussion Groups, Handouts, Blogs, News, etc.

International Resources
en Español






FDA Package Insert Resources

Indications

Contraindications

Side Effects

Drug Interactions

Precautions

Overdose

Instructions for Administration

How Supplied

Pharmacokinetics and Molecular Data

FDA label

FDA on Nefazodone

Return to top

Publication Resources

Most Recent Articles on Nefazodone

Review Articles on Nefazodone

Articles on Nefazodone in N Eng J Med, Lancet, BMJ

WikiDoc State of the Art Review

Textbook Information on Nefazodone

Return to top

Trial Resources

Ongoing Trials with Nefazodone at Clinical Trials.gov

Trial Results with Nefazodone

Return to top

Guidelines & Evidence Based Medicine Resources

US National Guidelines Clearinghouse on Nefazodone

Cochrane Collaboration on Nefazodone

Cost Effectiveness of Nefazodone

Return to top

Media Resources

Powerpoint Slides on Nefazodone

Images of Nefazodone

Podcasts & MP3s on Nefazodone

Videos on Nefazodone

Return to top

Patient Resources

Patient Information from National Library of Medicine

Patient Resources on Nefazodone

Discussion Groups on Nefazodone

Patient Handouts on Nefazodone

Blogs on Nefazodone

Nefazodone in the News

Nefazodone in the Marketplace

Return to top

International Resources

Nefazodone en Español

Return to top


The content of this page is taken from the FDA package insert for this drug and should not be edited.

Personal tools